✦ LIBER ✦

Welcome to the team: trastuzumab in HER2-positive esophagogastric cancers

✍ Scribed by Thomas J. George Jr.

Book ID: 118628033
Publisher: Frontline Medical Communications, Inc.
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 6
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70307-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab in HER2-positive advanced es

Trastuzumab in HER2-positive advanced esophagogastric adenocarcinoma

✍ Jame Abraham 📂 Article 📅 2009 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 57 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

306: Chemotherapy sensitizes p95HER2-pos

306: Chemotherapy sensitizes p95HER2-positive breast cancers to trastuzumab

✍ Morancho, B.; Parra-Palau, J.L.; Peg, V.; Vicario, R.; Zacarias-Fluck, M.; Peder 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 77 KB

HER2-Positive Breast Cancer: From Trastu

HER2-Positive Breast Cancer: From Trastuzumab to Innovatory Anti-HER2 Strategies

✍ Nicolas Whenham; Véronique D'Hondt; Martine J. Piccart 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 352 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 126 KB